Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases C Galván Casas, A Catala, G Carretero Hernández, ... British Journal of Dermatology 183 (1), 71-77, 2020 | 1706 | 2020 |
Cutaneous reactions after SARS‐CoV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases* A Català, C Muñoz‐Santos, C Galván‐Casas, M Roncero Riesco, ... British Journal of Dermatology 186 (1), 142-152, 2022 | 230 | 2022 |
CLOVES syndrome: review of a PIK3CA‐related overgrowth spectrum (PROS) A Martinez‐Lopez, G Blasco‐Morente, I Perez‐Lopez, JD Herrera‐Garcia, ... Clinical genetics 91 (1), 14-21, 2017 | 120 | 2017 |
Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment L Puig, JM Carrascosa, G Carretero, P De La Cueva, RF Lafuente-Urrez, ... Actas Dermo-Sifiliográficas (English Edition) 104 (8), 694-709, 2013 | 107 | 2013 |
Fundamentos de bioquímica estructural JM Teijón Editorial Tébar, 2006 | 100 | 2006 |
Off-label uses of anti-TNF therapy in three frequent disorders: Behçet’s disease, sarcoidosis, and noninfectious uveitis D Sánchez-Cano, JL Callejas-Rubio, R Ruiz-Villaverde, ... Mediators of Inflammation 2013, 2013 | 71 | 2013 |
Ultrasound as a diagnostic and management tool in hidradenitis suppurativa patients: a multicentre study A Martorell, F Alfageme Roldán, E Vilarrasa Rull, R Ruiz‐Villaverde, ... Journal of the European Academy of Dermatology and Venereology 33 (11), 2137 …, 2019 | 66 | 2019 |
Maculopapular eruptions associated to COVID‐19: a subanalysis of the COVID‐Piel study A Català, C Galván‐Casas, G Carretero‐Hernández, ... Dermatologic Therapy 33 (6), e14170, 2020 | 65 | 2020 |
Chilblain‐like lesions in pediatrics dermatological outpatients during the COVID‐19 outbreak G Garcia‐Lara, L Linares‐González, T Ródenas‐Herranz, ... Dermatologic therapy 33 (5), e13516, 2020 | 63 | 2020 |
Redefining the therapeutic objective in psoriatic patients candidates for biological therapy G Carretero, L Puig, JM Carrascosa, L Ferrándiz, R Ruiz-Villaverde, ... Journal of Dermatological Treatment 29 (4), 334-346, 2018 | 52 | 2018 |
Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis con agentes biológicos, 2013. I. Consideraciones de eficacia y selección del tratamiento L Puig, JM Carrascosa, G Carretero, P De la Cueva, RF Lafuente-Urrez, ... Actas Dermo-Sifiliográficas 104 (8), 694-709, 2013 | 48 | 2013 |
Treatment of moderate‐to‐severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series JC Armario‐Hita, J Pereyra‐Rodriguez, JF Silvestre, R Ruiz‐Villaverde, ... British Journal of Dermatology 181 (5), 1072-1074, 2019 | 46 | 2019 |
Successful treatment of type 1 pityriasis rubra pilaris with ustekinumab therapy RR Villaverde, DS Cano European Journal of Dermatology 20 (5), 630-631, 2010 | 40 | 2010 |
Bullous pemphigoid and COVID-19 vaccine I Pérez-López, D Moyano-Bueno, R Ruiz-Villaverde Medicina Clinica (English Ed.) 157 (10), e333, 2021 | 38 | 2021 |
Generalized annular granuloma: response to isotretinoin A Buendía‐Eisman, R Ruiz‐Villaverde, J Blasco‐Melguizo, ... International journal of dermatology 42 (4), 321-322, 2003 | 38 | 2003 |
Sexual distress in patients with hidradenitis suppurativa: a cross-sectional study C Cuenca-Barrales, R Ruiz-Villaverde, A Molina-Leyva Journal of clinical medicine 8 (4), 532, 2019 | 36 | 2019 |
Pilot study of sexual dysfunction in patients with psoriasis: influence of biologic therapy R Ruiz-Villaverde, D Sánchez-Cano, JR Rodrigo, CV Gutierrez Indian Journal of Dermatology 56 (6), 694, 2011 | 36 | 2011 |
Fifty‐two week follow‐up safety and effectiveness results of dupilumab treatment of moderate‐to‐severe atopic dermatitis from a retrospective, multicentric series R Ruiz‐Villaverde, J Dominguez‐Cruz, JC Armario‐Hita, L Martinez‐Pilar, ... Dermatologic therapy 32 (4), e12931, 2019 | 34 | 2019 |
Pitted keratolysis: an infective cause of foot odour P Fernández-Crehuet, R Ruiz-Villaverde CMAJ 187 (7), 519-519, 2015 | 34 | 2015 |
Basal cell carcinoma: treatment with imiquimod MP Bukhardt Pérez, R Ruiz‐Villaverde, MJ Naranjo Díaz, ... International journal of dermatology 46 (5), 539-542, 2007 | 33 | 2007 |